{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:03:09Z","timestamp":1787918589299,"version":"build-2784847793"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":4435,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s13311-011-0054-0","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T10:47:38Z","timestamp":1309344458000},"page":"463-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Risk Factors to Prevent Stroke"],"prefix":"10.1016","volume":"8","author":[{"given":"Junya","family":"Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-011-0054-0_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib3","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(04)16405-2","article-title":"Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)","volume":"363","author":"Rothwell","year":"2004","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/STROKEAHA.107.493643","article-title":"Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study","volume":"39","author":"Islam","year":"2008","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(10)60309-1","article-title":"Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00041552-199305000-00006","article-title":"Blood pressure variability and ambulatory monitoring","volume":"2","author":"Pickering","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1007\/s13311-011-0054-0_bib9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/hy1001.092640","article-title":"Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives","volume":"38","author":"Kario","year":"2001","journal-title":"Hypertension"},{"key":"10.1007\/s13311-011-0054-0_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/HYPERTENSIONAHA.110.151654","article-title":"Orthostatic hypotension is a more robust predictor of cardiovascular events than nighttime reverse dipping in elderly","volume":"56","author":"Fagard","year":"2010","journal-title":"Hypertension"},{"key":"10.1007\/s13311-011-0054-0_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-011-0054-0_bib12","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1007\/s13311-011-0054-0_bib13","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"10.1007\/s13311-011-0054-0_bib14","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1007\/s13311-011-0054-0_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"Thompson","year":"2011","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib18","doi-asserted-by":"crossref","unstructured":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981\u20132997.","DOI":"10.1001\/jama.288.23.2981"},{"key":"10.1007\/s13311-011-0054-0_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1007\/s13311-011-0054-0_bib21","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.STR.30.12.2517","article-title":"Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study","volume":"30","author":"Woo","year":"1999","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archneurol.2010.235","article-title":"Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study","volume":"67","author":"Rundek","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-011-0054-0_bib23","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.WNL.0000063318.66140.A3","article-title":"Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke","volume":"60","author":"Kernan","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib24","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib26","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCULATIONAHA.108.191305","volume":"119","author":"Skyler","year":"2009","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib29","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.298.10.1189","article-title":"Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2010.920","article-title":"Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone","volume":"304","author":"Graham","year":"2010","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.STR.0000257974.06317.49","article-title":"Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)","volume":"38","author":"Wilcox","year":"2007","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archinte.159.10.1097","article-title":"Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29","volume":"159","author":"Davis","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1007\/s13311-011-0054-0_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1007\/s13311-011-0054-0_bib36","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1532-5415.2004.52455.x","article-title":"The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study","volume":"52","author":"Psaty","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s13311-011-0054-0_bib39","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/archneurol.2009.210","article-title":"Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS)","volume":"66","author":"Willey","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-011-0054-0_bib40","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000144282.42222.DA","article-title":"Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups","volume":"63","author":"Tirschwell","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib41","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","article-title":"Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention","volume":"8","author":"Amarenco","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-011-0054-0_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib45","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.109.874834","article-title":"Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)","volume":"121","author":"Everett","year":"2010","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib47","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/STROKEAHA.108.534107","article-title":"Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes","volume":"40","author":"Amarenco","year":"2009","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib48","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","article-title":"Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"38","author":"Amarenco","year":"2007","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib49","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib50","series-title":"Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack","author":"Furie","year":"2010"},{"key":"10.1007\/s13311-011-0054-0_bib51","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/CIRCULATIONAHA.108.795666","article-title":"Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study","volume":"119","author":"Noda","year":"2009","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib53","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib54","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib55","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima-media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib56","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/01.CIR.103.23.2828","article-title":"Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"103","author":"Bloomfield Rubins","year":"2001","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib57","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib58","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1007\/s13311-011-0054-0_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.STR.0000254622.52483.03","article-title":"Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke","volume":"38","author":"Andersen","year":"2007","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib60","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1007\/s13311-011-0054-0_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib63","series-title":"ROCKETAF \u2014 Rivaroxaban Once-daily oral direct factor Xa inhibiation compared with vitamin K antagnosim for prevention of stroke and embolism Trial","author":"Mahaffey","year":"2010"},{"key":"10.1007\/s13311-011-0054-0_bib64","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib65","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib66","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jtcvs.2005.10.020","article-title":"Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis","volume":"131","author":"Barnett","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1007\/s13311-011-0054-0_bib67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1540-8167.2008.01285.x","article-title":"A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation","volume":"20","author":"Nair","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1007\/s13311-011-0054-0_bib68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2459\/JCM.0b013e328332e926","article-title":"Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials","volume":"11","author":"Bonanno","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1007\/s13311-011-0054-0_bib69","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcin.2009.05.005","article-title":"Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study","volume":"2","author":"Block","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1007\/s13311-011-0054-0_bib70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib71","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/erc.10.56","article-title":"Smoking and stroke: the more you smoke the more you stroke","volume":"8","author":"Shah","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1007\/s13311-011-0054-0_bib72","doi-asserted-by":"crossref","first-page":"b3060","DOI":"10.1136\/bmj.b3060","article-title":"Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis","volume":"339","author":"Boffetta","year":"2009","journal-title":"BMJ"},{"key":"10.1007\/s13311-011-0054-0_bib73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/STROKEAHA.107.494823","article-title":"The association of smoking and cardiovascular disease in a population with low cholesterol levels: a study of 648,346 men from the Korean National Health System Prospective Cohort Study","volume":"39","author":"Lawlor","year":"2008","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib74","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1001\/jama.299.17.2037","article-title":"Smoking and smoking cessation in relation to mortality in women","volume":"299","author":"Kenfield","year":"2008","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.STR.0000195048.86810.5b","article-title":"Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study","volume":"37","author":"Elkind","year":"2006","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib76","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00125-008-1031-y","article-title":"Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial","volume":"51","author":"Joosten","year":"2008","journal-title":"Diabetologia"},{"key":"10.1007\/s13311-011-0054-0_bib77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2458-10-258","article-title":"Alcohol consumption and the risk of morbidity and mortality for different stroke types \u2014 a systematic review and meta-analysis","volume":"10","author":"Patra","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1007\/s13311-011-0054-0_bib78","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.HYP.35.4.858","article-title":"National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence","volume":"35","author":"Chobanian","year":"2000","journal-title":"Hypertension"},{"key":"10.1007\/s13311-011-0054-0_bib79","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/oxfordjournals.aje.a112050","article-title":"Blood pressure in vegetarians","volume":"100","author":"Sacks","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1007\/s13311-011-0054-0_bib80","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(06)68069-0","article-title":"Fruit and vegetable consumption and stroke: meta-analysis of cohort studies","volume":"367","author":"He","year":"2006","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib82","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archinte.168.7.713","article-title":"Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women","volume":"168","author":"Fung","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1007\/s13311-011-0054-0_bib83","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(02)11472-3","article-title":"Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial","volume":"360","author":"Singh","year":"2002","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib84","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/01.wnl.0000324414.12665.b0","article-title":"Fish consumption and risk of subclinical brain abnormalities on MRI in older adults","volume":"71","author":"Virtanen","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib86","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/01.STR.0000091843.02517.9D","article-title":"Physical activity and stroke risk: a meta-analysis","volume":"34","author":"Lee","year":"2003","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ije\/dyh168","article-title":"Physical activity and stroke. A meta-analysis of observational data","volume":"33","author":"Wendel-Vos","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1007\/s13311-011-0054-0_bib88","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1001\/jama.286.22.2830","article-title":"Lack of clinical significance of early ischemic changes on computed tomography in acute stroke","volume":"286","author":"Patel","year":"2001","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib89","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archinternmed.2008.558","article-title":"Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial","volume":"169","author":"Davidson","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1007\/s13311-011-0054-0_bib90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/hs0202.102882","article-title":"Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise","volume":"33","author":"Greenlund","year":"2002","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib91","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/aje\/kwq369","article-title":"Physical activity and onset of acute ischemic stroke: the stroke onset study","volume":"173","author":"Mostofsky","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1007\/s13311-011-0054-0_bib92","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0054-0_bib93","doi-asserted-by":"crossref","unstructured":"Strazzullo P, D'Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke;41:e418-e426.","DOI":"10.1161\/STROKEAHA.109.576967"},{"key":"10.1007\/s13311-011-0054-0_bib94","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/STROKEAHA.110.593434","article-title":"Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox","volume":"42","author":"Vemmos","year":"2009","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib95","doi-asserted-by":"crossref","unstructured":"Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW. Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology;76:567\u2013573.","DOI":"10.1212\/WNL.0b013e31820b7667"},{"key":"10.1007\/s13311-011-0054-0_bib96","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1161\/STROKEAHA.109.550228","article-title":"The impact of body mass index on mortality after stroke","volume":"40","author":"Towfighi","year":"2009","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib97","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"37","author":"Goldstein","year":"2006","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib98","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.STR.0000204354.06965.44","article-title":"Metabolic syndrome and the risk of stroke in middle-aged men","volume":"37","author":"Kurl","year":"2006","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib99","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.47.5.1167","article-title":"Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients","volume":"47","author":"Bassetti","year":"1996","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib100","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/STROKEAHA.109.566745","article-title":"Auto-titrating continuous positive airway pressure for patients with acute transient ischemic attack: a randomized feasibility trial","volume":"41","author":"Bravata","year":"2010","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib101","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1378\/chest.128.4.2123","article-title":"Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke","volume":"128","author":"Martinez-Garcia","year":"2005","journal-title":"Chest"},{"key":"10.1007\/s13311-011-0054-0_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/rccm.200808-1341OC","article-title":"Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study","volume":"180","author":"Martinez-Garcia","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s13311-011-0054-0_bib103","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/01.CIR.0000068337.25994.21","article-title":"Obstructive sleep apnea and the recurrence of atrial fibrillation","volume":"107","author":"Kanagala","year":"2003","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib104","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib106","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1007\/s13311-011-0054-0_bib107","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1007\/s13311-011-0054-0_bib109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2009.12.023","article-title":"Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis","volume":"210","author":"Bruckert","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1007\/s13311-011-0054-0_bib110","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.281.19.1817","article-title":"Homocysteine and risk of cardiovascular disease among postmenopausal women","volume":"281","author":"Ridker","year":"1999","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib111","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1007\/s13311-011-0054-0_bib112","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies","volume":"3","author":"Den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1007\/s13311-011-0054-0_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2003.11.022","article-title":"Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence","volume":"176","author":"Durga","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1007\/s13311-011-0054-0_bib114","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0054-0_bib115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib116","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/STROKEAHA.110.595199","article-title":"Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?","volume":"41","author":"Morris","year":"2010","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib117","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/STROKEAHA.110.581256","article-title":"Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment","volume":"41","author":"Hamedani","year":"2010","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib118","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000251172","article-title":"Prognosis after cryptogenic cerebral ischemia in patients with coagulopathies","volume":"28","author":"Weber","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1007\/s13311-011-0054-0_bib119","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.109.913673","article-title":"Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies","volume":"121","author":"Kenet","year":"2010","journal-title":"Circulation"},{"key":"10.1007\/s13311-011-0054-0_bib120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1007\/s13311-011-0054-0_bib121","first-page":"2069","article-title":"The Antiphospholipid Antibodies in Stroke Study (APASS) Group","volume":"43","author":"Anticardiolipin antibodies are an independent risk factor for first ischemic stroke","year":"1993","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0054-0_bib122","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1007\/s13311-011-0054-0_bib123","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","article-title":"Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study","volume":"35","author":"Janardhan","year":"2004","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib124","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/01.STR.30.8.1561","article-title":"Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity","volume":"30","author":"Tuhrim","year":"1999","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.STR.31.6.1289","article-title":"Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project","volume":"31","author":"Ahmed","year":"2000","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0054-0_bib126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.291.5.576","article-title":"Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke","volume":"291","author":"Levine","year":"2004","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0054-0_bib127","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-011-0054-0_bib128","first-page":"1498","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Antiphospholipid syndrome. Lancet"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-011-0054-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0054-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:13:17Z","timestamp":1761808397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923018676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1878747923018676"],"URL":"https:\/\/doi.org\/10.1007\/s13311-011-0054-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Risk Factors to Prevent Stroke","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-011-0054-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}